Novartis to fill Pfizer-BioNTech vaccine in Ljubljana
Ljubljana, 21 October - Novartis has signed an initial agreement to use its manufacturing facility in Ljubljana to fill the Pfizer-BioNTech vaccine against Covid-19. The Novartis Technical Operations site in Ljubljana will fill at least 24 million doses in its sterile manufacturing facilities in 2022, the Swiss pharma company announced on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 1.146 characters (without spaces) or 208 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.